VNDA

VANDA PHARMACEUTICALS INC

VNDA·921659108·US·Common Stock·Healthcare - Biotechnology-13D/G

VNDA (VANDA PHARMACEUTICALS INC) is held by 107 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($46.8M), STATE STREET CORP ($21.5M), AQR CAPITAL MANAGEMENT LLC ($21.4M). Net institutional sentiment: Mixed.

107
Holders
(8 Elite)
$256.2M
Total Value
59% (110)
Consensus
65 buying - 45 selling
13F: Insider & Congress: Updated regularly
VNDA

Smart Money Verdict

View all
Loading verdict
Held by 107 funds
8 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Apr 24, 2026 · Activists Aug 19, 2026 · Congress none

ActivistMillennium Management LLCMillennium Management LLC5.6%Aug 19, 2026
ActivistAQR Capital Management, LLCAQR Capital Management, LLC5.8%Aug 13, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.1%May 12, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.7M(+5.2%)$46.8M0.0%+10.40%
31
Increased
3.5M(+16.6%)$21.5M0.0%-15.25%
33
Increased
3.5M(+118.1%)$21.4M0.0%-16.19%
46
Decreased
3.4M(-8.5%)$21.1M0.0%-51.14%
0
Increased
2.5M(+1.7%)$15.4M0.0%-31.51%
29
Decreased
1.7M(-2.5%)$10.6M0.0%-10.73%
0
Decreased
1.6M(-14.8%)$9.8M0.0%+5.57%
0
Increased
1.5M(+2.8%)$9.1M0.0%-58.57%
28
Decreased
1.3M(-3.5%)$8.3M0.0%-17.37%
0
Increased
1.2M(+105.7%)$7.5M0.0%-23.09%
44
Increased
1.2M(+3.8%)$7.4M0.0%-27.42%
28
Increased
1.1M(+11.5%)$6.9M0.0%-30.18%
30
Increased
1M(+23.6%)$6.3M0.0%-17.11%
33
Increased
758,302(+19.7%)$4.6M0.0%-29.20%
32
New
729,212$4.5M0.0%-12.58%
37
Increased
714,278(+24.1%)$4.4M0.0%-38.73%
33
Increased
646,256(+17.1%)$4M0.0%-63.70%
31
Increased
600,619(+33.2%)$3.7M0.0%-63.35%
34
Increased
477,974(+8.4%)$2.9M0.0%+3.43%
29
Increased
399,817(+3.1%)$2.4M0.0%-31.31%
27

Showing 1-20 of 117

1 / 6
VNDAVNDAVANDA PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used